Heparin remodels the microtubule-binding repeat R3 of Tau protein towards fibril-prone conformations
文献信息
Xuewei Dong, Ruxi Qi, Qin Qiao, Xuhua Li, Fangying Li, Jiaqian Wan, Qingwen Zhang, Guanghong Wei
Abnormal aggregation of proteins into pathological amyloid fibrils is implicated in a wide range of devastating human neurodegenerative diseases. Intracellular fibrillary inclusions formed by Tau protein are characterized as the hallmark of tauopathies, including Alzheimer's disease and frontotemporal dementia. Heparin has been often used to trigger Tau aggregation in in vitro studies. However, the conformational changes induced by heparin and the underlying mechanism of promotion of Tau aggregation by heparin are not well understood. Structural characterization of Tau oligomers in the early stage of fibrillation is of great importance but remains challenging due to their dynamic and heterogeneous nature. R3, the third microtubule-binding repeat of Tau, contains the fibril-nucleating core (PHF6) and is crucial for Tau aggregation. In this study, utilizing extensive all-atom replica-exchange molecular dynamic simulations, we explored the conformational ensembles of R3 monomer/dimer in the absence and presence of heparin. Our results show that without heparin, both monomeric and dimeric R3 preferentially adopt collapsed β-sheet-containing conformations and PHF6 plays an important role in the formation of interchain β-sheet structures, while in the presence of heparin, R3 can populate relatively extended disordered states where chain dimension is similar to that of R3 in Tau filaments. Through electrostatic, hydrogen-bonding and hydrophobic interactions, heparin has a preference for interacting with residues V306/Q307/K317/K321/H329/H330/K331 which distribute throughout the entire sequence of R3, in turn acting as a template to extend R3 conformations. More importantly, heparin alters intramolecular/intermolecular interaction patterns of R3 and increases the intermolecular contact regions. Our results suggest that heparin remodels the conformations of R3 towards fibril-prone structures by increasing chain dimension and intermolecular contact regions, which may shed light on the atomic mechanism of heparin-induced amyloid fibrillization of Tau protein.
期刊推荐
相关文献
Adiabatic and non-adiabatic corrections to rovibrational energies of diatomic molecules: variational calculations with experimental accuracy
DOI: 10.1039/B700044H
2H-solid state NMR and DSC study of isobutyric acid in mesoporous silica materials‡
Th. Emmler, I. Shenderovich, Y. Zeng, G. H. Findenegg, G. Buntkowsky
DOI: 10.1039/B617744A
Spectroscopy and potential energy surface of the H2–CO2 van der Waals complex: experimental and theoretical studies‡
A. R. W. McKellar, Dong H. Zhang
DOI: 10.1039/B614849B
Photocatalytic properties of titania nanostructured films fabricated from titania nanosheets
Tatsuo Shibata, Nobuyuki Sakai, Katsutoshi Fukuda, Yasuo Ebina, Takayoshi Sasaki
DOI: 10.1039/B618448K
Molecular orientational and dipolar correlation in the liquid crystal mixture E7: a molecular dynamics simulation study at a fully atomistic level
Jorge Peláez, Mark Wilson
DOI: 10.1039/B614422E
Anion photoelectron imaging of deprotonated thymine and cytosine
Bradley F. Parsons, Sean M. Sheehan, Terry A. Yen, Daniel M. Neumark, Nadine Wehres, Rainer Weinkauf
DOI: 10.1039/B703045B
Energy selective excision of CN− following electron attachment to hexafluoroacetone azine ((CF3)2CN–NC(CF3)2)
Ilko Bald, Iwona Dąbkowska, Eugen Illenberger, Oddur Ingólfsson
DOI: 10.1039/B702482G
On the curvature dependence of the interfacial tension in a symmetric three-component interface
DOI: 10.1039/B613074G
您可能还喜欢
(5-氨基吡唑-3-基)乙酸(CAS号:174891-10-2)的物理化学性质是什么?
(5-氨基吡唑-3-基)乙酸是一种无色至白色固体,分子量为174.15 g/mol。它在水中具有较好的溶解性,在有机溶剂中的溶解度较低。该化合物具有较好的反应活...
3-氟-4,5-二氯苯胺(CAS号:35754-38-2)适用哪些法规指南?
3-氟-4,5-二氯苯胺受到多项法规指南的约束,包括但不限于GHS(全球化学品统一分类和标签制度)的危险分类标准、欧盟的REACH法规(注册、评估、授权和限制)...
什么是(R)-(+)-2,2',6,6'-四甲氧基-4,4'-联(二(3,5-二甲苯基基)膦基)-3,3'-二联吡啶(CAS号:442905-33-1)?
这是一种有机化合物,化学名为(R)-(+)-2,2',6,6'-四甲氧基-4,4'-联(二(3,5-二甲苯基基)膦基)-3,3'-二联吡啶,CAS号为44290...
1-氨基-2-氰基萘(CAS号:3100-67-2)应用于哪些行业?
1-氨基-2-氰基萘在医药、聚合物、传感器和半导体等行业中有应用。在医药领域,它可用作中间体合成某些药物。在聚合物行业,它可以用于制备具有特定性能的聚合物。此外...
如何处理含有1-溴-4-(异丙氧基甲基)苯(CAS号:98446-84-5)的废料?
处理含1-溴-4-(异丙氧基甲基)苯的废料时,首先应确保废液收集在防渗漏的容器中,避免泄露。然后,可以考虑采用化学降解法或物理吸附法进行处理。在特定条件下,可通...
6-Chloro-8-(trifluoromethyl)chroman-4-one(CAS号:1344889-75-3)的主要用途是什么?
6-氯-8-三氟甲基-2,3-二氢-4H-色喃-4-酮主要用于有机合成中的中间体,也可作为研究试剂使用。
7-乙氧基-2-萘酚(CAS号:57944-44-2)通常如何合成?
7-乙氧基-2-萘酚通常通过N-乙氧基化反应合成,首先将2-萘酚与乙醇钠在乙醇中反应生成7-乙氧基-2-萘酚钠盐,再通过酸化进一步得到7-乙氧基-2-萘酚。该合...
4-(1,1-二氧硫代吗啉)丁醇(CAS号:59801-41-1)适用哪些法规指南?
该化合物需遵循一系列的法规指南,包括但不限于GHS全球统一分类和标签制度,其分类可能包括易燃液体和可能危害水生环境。在欧洲,还需遵循REACH法规,确保物质和混...
4-甲氧基苄基叠氮甲酸酯(CAS号:25474-85-5)的物理化学性质是什么?
4-甲氧基苄基叠氮甲酸酯是一种无色液体,具有一定的挥发性。其分子量为198.16,熔点为-69°C,沸点为105°C。该化合物在水中溶解度较低,在有机溶剂如乙醇...
如何处理含有4-氯-2-氟嘧啶(CAS号:51422-00-5)的废料?
含有4-氯-2-氟嘧啶的废料应按照危险废物处理。首先,应收集并分类这些废料,避免与其他废物混合。然后,可以采用焚烧处理或者交由专业机构进行处置。在处理过程中,需...
来源期刊
Physical Chemistry Chemical Physics

Physical Chemistry Chemical Physics (PCCP) is an international journal co-owned by 19 physical chemistry and physics societies from around the world. This journal publishes original, cutting-edge research in physical chemistry, chemical physics and biophysical chemistry. To be suitable for publication in PCCP, articles must include significant innovation and/or insight into physical chemistry; this is the most important criterion that reviewers and Editors will judge against when evaluating submissions. The journal has a broad scope and welcomes contributions spanning experiment, theory, computation and data science. Topical coverage includes spectroscopy, dynamics, kinetics, statistical mechanics, thermodynamics, electrochemistry, catalysis, surface science, quantum mechanics, quantum computing and machine learning. Interdisciplinary research areas such as polymers and soft matter, materials, nanoscience, energy, surfaces/interfaces, and biophysical chemistry are welcomed if they demonstrate significant innovation and/or insight into physical chemistry. Joined experimental/theoretical studies are particularly appreciated when complementary and based on up-to-date approaches.












![1-[6-(1H-Imidazol-1-yl)-3-pyridinyl]methanamine structure 1-[6-(1H-Imidazol-1-yl)-3-pyridinyl]methanamine structure](https://cnstatic.chemtradehub.com/structs/914/914637-08-4-8825.webp)
![N-{15-[(2,5-Dioxo-1-pyrrolidinyl)oxy]-15-oxo-3,6,9,12-tetraoxapentadec-1-yl}-2-(2-propyn-1-yloxy)acetamide structure N-{15-[(2,5-Dioxo-1-pyrrolidinyl)oxy]-15-oxo-3,6,9,12-tetraoxapentadec-1-yl}-2-(2-propyn-1-yloxy)acetamide structure](https://cnstatic.chemtradehub.com/structs/210/2101206-92-0-2eb5.webp)
